The FDA recently approved a new rapid-acting mealtime insulin called Lyumjev, which is absorbed into the body more quickly than Humalog and is designed to target post-meal spikes and reduce A1c.
[read_more text="read more" title="read more" url="https://tcoyd.org/2020/07/lyumjev-the-new-ultra-rapid-acting-insulin-that-fits-around-your-lifestyle/" align="left"]